Effectdossier · gearchiveerd kwartaal
OPK
OPKO Health, Inc. · Healthcare · Medical - Diagnostics & Research
15Gevolgde houders
0Δ houders
96.47MGehouden aandelen
$127.34MGerapporteerde waarde
+2Nieuwe posities
−2Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -11.2% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | -5 | 114.41M | $171.44M | +3 | −8 |
| Q1 2026 | 91 | +2 | 116.06M | $132.34M | +8 | −6 |
| Q4 2025 | 88 | 0 | 132.71M | $167.24M | +1 | −1 |
| Q3 2025 | 15 | -2 | 100.01M | $155.02M | — | −3 |
| Q2 2025 | 15 | 0 | 96.47M | $127.34M | +2 | −2 |
| Q1 2025 | 12 | +1 | 38.88M | $64.54M | +2 | −1 |
| Q4 2024 | 11 | -1 | 30.02M | $44.13M | — | −1 |
| Q3 2024 | 11 | +1 | 16.46M | $24.53M | +1 | — |
| Q2 2024 | 10 | — | 13.40M | $16.75M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 38.24M | — | $50.48M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 38.24M | — | $50.48M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 38.24M | — | $50.48M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 38.24M | — | $50.48M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 38.24M | — | $50.48M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 31.45M | — | $41.51M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passief) | 10.42M | +23.7% | $13.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passief) | 10.42M | +23.7% | $13.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (passief) | 8.58M | +5.4% | $11.33M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Marshall Wace ✦ | 3.35M | -31.6% | $4.42M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Marshall Wace ✦ | 3.35M | -31.6% | $4.42M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 1.84M | +11.6% | $2.42M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 935.90K | -41.8% | $1.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 935.90K | -41.8% | $1.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 935.90K | -41.8% | $1.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 935.90K | -41.8% | $1.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 935.90K | -41.8% | $1.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | Millennium Management ✦ | 695.78K | -89.1% | $918,430 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | T. Rowe Price ✦ | 437.51K | -12.8% | $578,000 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 217.40K | -88.3% | $286,961 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | GAMCO Investors ✦ | 175.00K | 0.0% | $231,000 | 0.0% | Held | 5 | SEC ↗ |
| 34 | Norges Bank ✦ (passief) | 39.48K | -92.0% | $52,110 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Renaissance Technologies ✦ | 38.10K | Nieuw | $50,292 | 0.0% | New | 1 | SEC ↗ |
| 36 | Fisher Asset Management ✦ | 30.30K | Nieuw | $39,997 | 0.0% | New | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 16.12K | — | $21,280 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 16.12K | — | $21,280 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 16.12K | — | $21,280 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $50,292 | 0.0% |
| Fisher Asset Management | $39,997 | 0.0% |
Verlaten
| D. E. Shaw & Co. | $7.85M | was 0.0% |
| Gotham Asset Management | $18,353 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 231 houders, 200.30M aandelen, $226.79M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API